These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30442375)

  • 81. Clinical, echocardiographic, and hemodynamic characteristics of rheumatic mitral valve stenosis and atrial fibrillation.
    Kabukçu M; Arslantas E; Ates I; Demircioglu F; Ersel F
    Angiology; 2005; 56(2):159-63. PubMed ID: 15793605
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Echocardiographic assessment of left ventricular diastolic function and filling pressure in atrial fibrillation.
    Al-Omari MA; Finstuen J; Appleton CP; Barnes ME; Tsang TS
    Am J Cardiol; 2008 Jun; 101(12):1759-65. PubMed ID: 18549855
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation.
    Arribas F; Ormaetxe JM; Peinado R; Perulero N; Ramírez P; Badia X
    Europace; 2010 Mar; 12(3):364-70. PubMed ID: 20056594
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Correlation between plasma brain natriuretic peptide levels and left atrial appendage flow velocity in patients with non-valvular atrial fibrillation and normal left ventricular systolic function.
    Harada M; Tabako S; Fujii Y; Takarada Y; Hayashi K; Ohara H; Hara F; Ikeda T
    J Echocardiogr; 2018 Jun; 16(2):72-80. PubMed ID: 29256043
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    Saksena S; Slee A; Saad M
    J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life.
    Guédon-Moreau L; Capucci A; Denjoy I; Morgan CC; Périer A; Leplège A; Kacet S
    Europace; 2010 May; 12(5):634-42. PubMed ID: 20154349
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study.
    Bang CN; Dalsgaard M; Greve AM; Køber L; Gohlke-Baerwolf C; Ray S; Rossebø AB; Egstrup K; Wachtell K
    Int J Cardiol; 2013 Oct; 168(3):2322-7. PubMed ID: 23416018
    [TBL] [Abstract][Full Text] [Related]  

  • 88. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function.
    Stevenson IH; Teichtahl H; Cunnington D; Ciavarella S; Gordon I; Kalman JM
    Eur Heart J; 2008 Jul; 29(13):1662-9. PubMed ID: 18515807
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.
    Dorian P; Jung W; Newman D; Paquette M; Wood K; Ayers GM; Camm J; Akhtar M; Luderitz B
    J Am Coll Cardiol; 2000 Oct; 36(4):1303-9. PubMed ID: 11028487
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Both beat-to-beat changes in RR-interval and left ventricular filling time determine ventricular function during atrial fibrillation.
    Lyon A; van Mourik M; Cruts L; Heijman J; Bekkers SCAM; Schotten U; Crijns HJGM; Linz D; Lumens J
    Europace; 2021 Mar; 23(23 Suppl 1):i21-i28. PubMed ID: 33751072
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Association between personality type and patient-reported outcomes (PRO) in patients with atrial fibrillation.
    Yan Q; Liang J; Yuan Y; Li Y; Fan J; Wu W; Xu P; Wang Q; Xue J
    BMC Cardiovasc Disord; 2024 Aug; 24(1):437. PubMed ID: 39174904
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale.
    Dorian P; Cvitkovic SS; Kerr CR; Crystal E; Gillis AM; Guerra PG; Mitchell LB; Roy D; Skanes AC; Wyse DG
    Can J Cardiol; 2006 Apr; 22(5):383-6. PubMed ID: 16639472
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification.
    Wynn GJ; Todd DM; Webber M; Bonnett L; McShane J; Kirchhof P; Gupta D
    Europace; 2014 Jul; 16(7):965-72. PubMed ID: 24534264
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Association of sex, age and education level with patient reported outcomes in atrial fibrillation.
    Gleason KT; Dennison Himmelfarb CR; Ford DE; Lehmann H; Samuel L; Han HR; Jain SK; Naccarelli GV; Aggarwal V; Nazarian S
    BMC Cardiovasc Disord; 2019 Apr; 19(1):85. PubMed ID: 30953478
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation.
    Witassek F; Springer A; Adam L; Aeschbacher S; Beer JH; Blum S; Bonati LH; Conen D; Kobza R; Kühne M; Moschovitis G; Osswald S; Rodondi N; Sticherling C; Szucs T; Schwenkglenks M;
    PLoS One; 2019; 14(12):e0226730. PubMed ID: 31869399
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Burden of Psychosocial and Cognitive Impairment in Patients With Atrial Fibrillation.
    Bostrom JA; Saczynski JS; Hajduk A; Donahue K; Rosenthal LS; Browning C; Ennis C; Floyd KC; Richardson H; Esa N; Ogarek J; McManus DD
    Crit Pathw Cardiol; 2017 Jun; 16(2):71-75. PubMed ID: 28509707
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Importance and Assessment of Quality of Life in Symptomatic Permanent Atrial Fibrillation: Patient Focus Groups from the RATE-AF Trial.
    Jones J; Stanbury M; Haynes S; Bunting KV; Lobban T; Camm AJ; Calvert MJ; Kotecha D;
    Cardiology; 2020; 145(10):666-675. PubMed ID: 32862174
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Patient-reported outcomes and subsequent management in atrial fibrillation clinical practice: Results from the Utah mEVAL AF program.
    Zenger B; Zhang M; Lyons A; Bunch TJ; Fang JC; Freedman RA; Navaravong L; Piccini JP; Ranjan R; Spertus JA; Stehlik J; Turner JL; Greene T; Hess R; Steinberg BA
    J Cardiovasc Electrophysiol; 2020 Dec; 31(12):3187-3195. PubMed ID: 33124710
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Discrepancy in recognition of symptom burden among patients with atrial fibrillation.
    Katsumata Y; Kimura T; Kohsaka S; Ikemura N; Ueda I; Fujisawa T; Nakajima K; Nishiyama T; Aizawa Y; Oki T; Suzuki M; Heidenreich PA; Fukuda K; Takatsuki S
    Am Heart J; 2020 Aug; 226():240-249. PubMed ID: 32517853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.